These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 28396115

  • 21. Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes.
    Panduru NM, Sandholm N, Forsblom C, Saraheimo M, Dahlström EH, Thorn LM, Gordin D, Tolonen N, Wadén J, Harjutsalo V, Bierhaus A, Humpert PM, Groop PH, FinnDiane Study Group.
    Diabetes Care; 2015 Jun; 38(6):1130-7. PubMed ID: 25784666
    [Abstract] [Full Text] [Related]

  • 22. Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.
    Vélayoudom-Céphise FL, Rajaobelina K, Helmer C, Nov S, Pupier E, Blanco L, Hugo M, Farges B, Astrugue C, Gin H, Rigalleau V.
    Cardiovasc Diabetol; 2016 Sep 01; 15(1):127. PubMed ID: 27585632
    [Abstract] [Full Text] [Related]

  • 23. High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy.
    Fernández-Juárez G, Villacorta Perez J, Luño Fernández JL, Martinez-Martinez E, Cachofeiro V, Barrio Lucia V, Tato Ribera AM, Mendez Abreu A, Cordon A, Oliva Dominguez JA, Praga Terente M.
    Nephrology (Carlton); 2017 May 01; 22(5):354-360. PubMed ID: 27003829
    [Abstract] [Full Text] [Related]

  • 24. Identification of Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling in a Multicenter Prospective Cohort Study: U-CARE Study 1.
    Mise K, Imamura M, Yamaguchi S, Teshigawara S, Tone A, Uchida HA, Eguchi J, Nakatsuka A, Ogawa D, Yoshida M, Yamada M, Shikata K, Wada J.
    Diabetes Care; 2018 Aug 01; 41(8):1765-1775. PubMed ID: 29930140
    [Abstract] [Full Text] [Related]

  • 25. Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.
    Fufaa GD, Weil EJ, Lemley KV, Knowler WC, Brosius FC, Yee B, Mauer M, Nelson RG.
    Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):254-61. PubMed ID: 26792530
    [Abstract] [Full Text] [Related]

  • 26. Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
    Amanzadeh M, Mota A, Zarghami N, Abedi-Azar S, Abroon S, Akbarian N, Mihanfar A, Rahmati-Yamchi M.
    Iran J Kidney Dis; 2018 Jan 05; 12(1):40-47. PubMed ID: 29421776
    [Abstract] [Full Text] [Related]

  • 27. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H, Li G, Tomlin A, Tilyard MW, Walker R, Schollum J.
    Nephrology (Carlton); 2019 Mar 05; 24(3):308-315. PubMed ID: 29717528
    [Abstract] [Full Text] [Related]

  • 28. Change in albuminuria and eGFR following insulin sensitization therapy versus insulin provision therapy in the BARI 2D study.
    August P, Hardison RM, Hage FG, Marroquin OC, McGill JB, Rosenberg Y, Steffes M, Wall BM, Molitch M, BARI 2D Study Group.
    Clin J Am Soc Nephrol; 2014 Jan 05; 9(1):64-71. PubMed ID: 24178969
    [Abstract] [Full Text] [Related]

  • 29. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC, Susanto H, Chuang WH, Liu TY, Wang CH.
    Cardiovasc Diabetol; 2016 Jan 07; 15():3. PubMed ID: 26739836
    [Abstract] [Full Text] [Related]

  • 30. Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus.
    Colombo M, McGurnaghan SJ, Bell S, MacKenzie F, Patrick AW, Petrie JR, McKnight JA, MacRury S, Traynor J, Metcalfe W, McKeigue PM, Colhoun HM, Scottish Diabetes Research Network (SDRN) Type 1 Bioresource Investigators and the Scottish Renal Registry.
    Diabetologia; 2020 Mar 07; 63(3):636-647. PubMed ID: 31807796
    [Abstract] [Full Text] [Related]

  • 31. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
    Saulnier PJ, Dieter BP, Tanamas SK, McPherson SM, Wheelock KM, Knowler WC, Looker HC, Meek RL, Nelson RG, Tuttle KR.
    Am J Nephrol; 2017 Mar 07; 46(4):276-284. PubMed ID: 28934744
    [Abstract] [Full Text] [Related]

  • 32. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S, Hansen TW, Rossing P.
    Am J Hypertens; 2014 Sep 07; 27(9):1152-9. PubMed ID: 24627444
    [Abstract] [Full Text] [Related]

  • 33. Diabetic kidney disease and vascular comorbidities in patients with type 2 diabetes mellitus in a developing country.
    Bentata Y, Chemlal A, Karimi I, El Alaoui F, Haddiya I, Abouqal R.
    Saudi J Kidney Dis Transpl; 2015 Sep 07; 26(5):1035-43. PubMed ID: 26354588
    [Abstract] [Full Text] [Related]

  • 34. The influence of sex on renal function decline in people with Type 2 diabetes.
    de Hauteclocque A, Ragot S, Slaoui Y, Gand E, Miot A, Sosner P, Halimi JM, Zaoui P, Rigalleau V, Roussel R, Saulnier PJ, Hadjadj Samy S, SURDIAGENE Study group.
    Diabet Med; 2014 Sep 07; 31(9):1121-8. PubMed ID: 24773061
    [Abstract] [Full Text] [Related]

  • 35. Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes.
    Skupien J, Warram JH, Smiles AM, Stanton RC, Krolewski AS.
    Diabetes Care; 2016 Dec 07; 39(12):2262-2269. PubMed ID: 27647852
    [Abstract] [Full Text] [Related]

  • 36. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
    Kim JH, Kim SS, Kim IJ, Lee MJ, Jeon YK, Kim BH, Song SH, Kim YK.
    J Diabetes Complications; 2017 Feb 07; 31(2):395-399. PubMed ID: 27913013
    [Abstract] [Full Text] [Related]

  • 37. Improved prognosis of diabetic nephropathy in type 1 diabetes.
    Andrésdóttir G, Jensen ML, Carstensen B, Parving HH, Hovind P, Hansen TW, Rossing P.
    Kidney Int; 2015 Feb 07; 87(2):417-26. PubMed ID: 24918158
    [Abstract] [Full Text] [Related]

  • 38. Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.
    Krolewski AS.
    Diabetes Care; 2015 Jun 07; 38(6):954-62. PubMed ID: 25998286
    [Abstract] [Full Text] [Related]

  • 39. Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.
    Rossing P, Block GA, Chin MP, Goldsberry A, Heerspink HJL, McCullough PA, Meyer CJ, Packham D, Pergola PE, Spinowitz B, Sprague SM, Warnock DG, Chertow GM.
    Kidney Int; 2019 Oct 07; 96(4):1030-1036. PubMed ID: 31377056
    [Abstract] [Full Text] [Related]

  • 40. [Natural history of diabetic nephropathy].
    Ishimura E.
    Nihon Rinsho; 2005 Jun 07; 63 Suppl 6():324-30. PubMed ID: 15999728
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.